Announcement Alzheon Inc., a clinical-level biopharmaceutical company upgrading in diagnostics and therapeutics for the Alzheimer’s disease (AD) patient group, has confirmed that they will present new safety and efficacy data from the Phase 2 study, lasting for over 3 years. The company will...
Announcement Beacon Biosignals, a well-known neurotechnology company fueling precision medicines and AI-boosted neurodiagnostics for the brain, has expanded its smart partnership with Takeda, which was initiated in 2024, paving the way for success. This expansion accelerates the Beacon Platform to...
Announcement Defence Therapeutics Inc., a known biotechnology company brilliantly working and sharpening its focus on next-generation antibody-drug conjugate (ADC), have climbed one step ahead on the ladder of one more milestone by making an effort to fight cancer that goes beyond the ADC's recent ...
Announcement Lumenis Be. Ltd, a pioneering energy-related medical device company, has entered the healthcare market with its new edition of its breakthrough multi-application aesthetic platform, the Stellar M22™, equipped with XPL™ Technology, sponsored by four comprehensive technologie...
Announcement HCW Biologics Inc., a US-based clinical-level biopharmaceutical company aimed at establishing and exploring new innovative immunotherapies to expand healthspan by focusing on the connection between chronic disease and inflammation, proudly declared its dosage completion on the first p...
Announcement Emulate, Inc., a known provider of next-generation Organ-on-a-Chip technology, in collaboration with FUJIFILM Cellular Dynamics Inc., a leading global manufacturer and creator of human induced pluripotent stem cells (iPSCs), has introduced the Emulate Brain-Chip R1. The first-ever and...
Announcement Hemostemix Inc., a known champion in regenerative medicine, will be at the Innovations in Wound Care Conference in Key West, Florida, scheduled from December 11-14, 2025. The company will flaunt its world-class angiogenic cell therapy, ACP-01. The therapy, which heals ulcers, reduces ...
Announcement Medexus Pharmaceuticals has joined hands with the National Bank of Canada as an administrative agent under the new senior secured credit agreement. This new credit agreement will deliver US$21.0 million term loan facility and a revolving loan facility worth US$5.0. The term loan facili...
Announcement Augurex Life Sciences Corp., a key player in the establishment of autoimmune-related diagnostics, have introduced its upcoming 14-3-3eta test to soon ramp the official stage. The 14-3-3eta test is approved as JOINTstat® in the UK and Canada and came into recognition via Sonic Refer...
Announcement Eli Lilly's back-to-back acquisitions are making headlines, and now the company has signed one more cheque to purchase South Korea’s ABL Bio to gain access to reliable technology and bolster and expand its pipeline. Neither company has disclosed their planning for the programs t...
